<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJPed</journal-id><journal-title-group><journal-title>Open Journal of Pediatrics</journal-title></journal-title-group><issn pub-type="epub">2160-8741</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojped.2019.93024</article-id><article-id pub-id-type="publisher-id">OJPed-95512</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Acute Renal Failure in Children at the University Hospital of Brazzaville
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Engoba</surname><given-names>Moyen</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Verlem</surname><given-names>Bomelefa-Bomel</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gaston</surname><given-names>Ekouya-Bowassa</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tony</surname><given-names>Eyeni Sinomono</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Aymar</surname><given-names>Pierre Gildas Oko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bertrand</surname><given-names>Fikahem Ellenga Mbolla</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Georges</surname><given-names>Marius Moyen</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff4"><addr-line>Cardiology Department, University Hospital of Brazzaville, Brazzaville, Congo</addr-line></aff><aff id="aff2"><addr-line>Neonatology Department, University Hospital of Brazzaville, Brazzaville, Congo</addr-line></aff><aff id="aff3"><addr-line>Nephrology Department, University Hospital of Brazzaville, Brazzaville, Congo</addr-line></aff><aff id="aff1"><addr-line>Intensive Care Pediatric Department, University Hospital of Brazzaville, Brazzaville, Congo</addr-line></aff><pub-date pub-type="epub"><day>09</day><month>07</month><year>2019</year></pub-date><volume>09</volume><issue>03</issue><fpage>253</fpage><lpage>272</lpage><history><date date-type="received"><day>30,</day>	<month>August</month>	<year>2019</year></date><date date-type="rev-recd"><day>27,</day>	<month>September</month>	<year>2019</year>	</date><date date-type="accepted"><day>30,</day>	<month>September</month>	<year>2019</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction:
   Acute renal failure (ARF) is a medical emergency that does not spare children. Its interest lies in the search for etiologies and management made difficult by the poor quality of hospital technical platform in Africa. <b>Objectives:</b> To improve the management of ARF in children, determine its prevalence, and identify the causes and factors associated with mortality. <b>Patients and Methods:</b> We reviewed the records of children from one month to 17 years hospitalized between January 2016 and December 2018 in every pediatric department at the University Hospital of Brazzaville and included those whose discharge diagnosis included the item “ARF”. Study variables were age, sex,
   source, (para)clinical signs, stage and type of ARF, etiology and evolutionary profile. <b>Results:</b> Included were 18952 hospitalized children out of whose 253 had ARF 1.3%. There 
  were 145 (57.3%) boys and 108 (42.7%) girls with an average age of 71.5
   months. The mean time to consultation was 8.1 days. ARF was at failure stage in 147 cases (58.1%). It was functional in 210 cases (83.0%), out of which 95.1% resulted from severe dehydration. No extra-renal treatment was performed. Lethality was 34.4%. Hypovolemic shock (56.3%), severe sepsis (18.4%) and severe malaria (14.9%) were the main causes. Young age, provenance of the child, severe dehydration, deep coma, oligoanuria, stage of failure, hyperkalemia, absence of an extra-renal purification center were factors associated with mortality (p &lt; 0.0002).<b> Conclusion:</b> The high prevalence of ARF and its lethality requires public health actions including proper management of dehydration and malaria but also the creation of an extra-renal purification center.
 
</p></abstract><kwd-group><kwd>Acute Renal Failure</kwd><kwd> Child</kwd><kwd> Brazzaville</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Acute renal failure (ARF), a rapid deterioration of renal function resulting in elevated plasma creatinine and inability of the kidney to eliminate waste nitrogen metabolism and maintain the body’s electrolytic balance [<xref ref-type="bibr" rid="scirp.95512-ref1">1</xref>] , is a medical emergency. It is reversible in most cases, but may be life-threatening [<xref ref-type="bibr" rid="scirp.95512-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref2">2</xref>] . It is one of the leading causes of morbidity and mortality in children [<xref ref-type="bibr" rid="scirp.95512-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref4">4</xref>] . Its pediatric prevalence is 0.8 per 100,000 habitants in the United Kingdom [<xref ref-type="bibr" rid="scirp.95512-ref5">5</xref>] , 0.39% in the United States [<xref ref-type="bibr" rid="scirp.95512-ref6">6</xref>] , 4.5% in Canada [<xref ref-type="bibr" rid="scirp.95512-ref7">7</xref>] , with mortality rates of 25%, 15.3%, 3.5%. In Africa, some hospital surveys are reported by Aloni in the Democratic Republic of Congo (DRC): 1.78% [<xref ref-type="bibr" rid="scirp.95512-ref8">8</xref>] , Keita in Senegal: 0.91% [<xref ref-type="bibr" rid="scirp.95512-ref9">9</xref>] , Ifeoma in Nigeria: 1.0% [<xref ref-type="bibr" rid="scirp.95512-ref10">10</xref>] and Coulibaly in Burkina Faso: 3.3% [<xref ref-type="bibr" rid="scirp.95512-ref11">11</xref>] with respectively 25%, 34%, 40.5%, 10.1% of deaths. The diagnosis of ARF is made by biological examinations and its management depends on the causes.</p><p>In Congo, according to Assounga [<xref ref-type="bibr" rid="scirp.95512-ref12">12</xref>] , the pediatric frequency of the ARF at the University Hospital of Brazzaville in 2000 was 0.99% with 37% of deaths. Recently, seventeen years later, our study was carried out in the same hospital, and intended to contribute to improving the management of inpatient children with ARF and aimed to: determine epidemiological aspects of pediatric ARF, identify causes, describe the evolutionary profile and identify factors associated with mortality.</p></sec><sec id="s2"><title>2. Methodology</title><p>It was a cross-sectional, retrospective study conducted from January 2016 to December 2018 at the University Hospital of Brazzaville, a Level III health facility. It has 22 clinical departments, including three pediatric departments (infant, older children and intensive care), which are part of the study.</p><p>Children aged from one month to 17 years, hospitalized in one of the pediatric departments, and whose discharge diagnosis included among others the item ARF were included.</p><p>Newborns and children hospitalized for chronic renal failure were not included. Inaccurate records, duplicates, and children with uncomplicated renal disease were excluded.</p><p>This sample was exhaustive. The data was collected on a pre-established survey form.</p><p>The variables studied were: socio-demographic: age, sex, place of residence and provenance of the child; the age, occupation, education and socio-economic status of the parents; Clinical: period and motive of hospitalization, symptoms presented before admission and at admission: diuresis, presence of edema, temperature, respiratory distress, state of consciousness, state of hydration and nutritional, paleness, blood pressure. Para-clinical variables: serum creatinine, blood urea, hemogram, blood ionogram, serum calcium, phosphoremia, bicarbonate, blood gas, haptoglobin, blood smear, C3 complement, coombs test, urine test strip, 24-hour proteinuria, urine cytobacteriological examination (UCBE), electrocardiogram, renal and/or abdominal ultrasound, chest X-ray, abdominal radiography without preparation, percutaneous renal biopsy (PRB).</p><p>Other variables: stage of ARF, type of ARF, etiology of ARF, treatment, evolution.</p><sec id="s2_1"><title>2.1. Operational Definitions</title><p>ARF was defined as a rapid and usually reversible decrease in the glomerular filtration rate leading to uremia and fluid and electrolyte disturbances. It is characterized by a recent elevation (&lt;3 months) of serum creatinine, which may display preserved diuresis (&gt;500 ml/24h) or oliguria (100 - 500 ml/24h) or anuria (&lt;100ml/24h) [<xref ref-type="bibr" rid="scirp.95512-ref13">13</xref>] .</p><p>The staging of the ARF used was that of the modified RIFLE (<xref ref-type="table" rid="table1">Table 1</xref>) classification for pediatrics (pRIFLE) [<xref ref-type="bibr" rid="scirp.95512-ref14">14</xref>] . The estimated clearance of creatinine is calculated according to Schwartz’s pediatric formula [<xref ref-type="bibr" rid="scirp.95512-ref15">15</xref>] and compared to a reference value of 100 ml/min/1.73m<sup>2</sup> in the absence of a known prior value.</p><p>Acute renal failure is called functional or pre-renal, when there is a decrease in glomerular perfusion; organic or intrinsic, a dysfunction of different renal structures (tubules, glomeruli, interstitium or vessels) and obstructive or post-renal, when there is an obstacle on the urinary tract [<xref ref-type="bibr" rid="scirp.95512-ref16">16</xref>] .</p><p>Complete recovery of renal function: was defined by the normalization of serum creatinine and blood urea output.</p><p>Partial recovery of renal function: was defined as resumption of diuresis with improvement of renal function without normalization of serum creatinine and/or blood urea. Chronicity: was defined by the lack of normalization of renal function beyond three months.</p></sec><sec id="s2_2"><title>2.2. Statistical Analysis</title><p>The data were entered and processed using SPSS version 20.0 and Microsoft Excel 2010. The qualitative and quantitative variables were expressed in percentages &#177; standard deviation, respectively. The comparison of the means between variables was performed by Pearson’s chi-square for qualitative variables, the Student’s test for quantitative variables. The Odd Ratio (OR) calculation and their confidence interval (CI) were required. The threshold of significance was set at 0.05.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Modified RIFLE for ARF classification in pediatrics [<xref ref-type="bibr" rid="scirp.95512-ref14">14</xref>] </title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Stage</th><th align="center" valign="middle" >Estimated clearance plasma creatinine</th><th align="center" valign="middle" >Diuresis</th></tr></thead><tr><td align="center" valign="middle" >Risk</td><td align="center" valign="middle" >Reduced to &gt;25%</td><td align="center" valign="middle" >&lt;0.5 ml/kg/h since 8 h</td></tr><tr><td align="center" valign="middle" >Injury</td><td align="center" valign="middle" >Reduced to &gt;50%</td><td align="center" valign="middle" >&lt;0.5 ml/kg/h since 16 h</td></tr><tr><td align="center" valign="middle" >Failure</td><td align="center" valign="middle" >Reduced to &gt;75% or &lt;35/ml/min/1.73 m<sup>2</sup></td><td align="center" valign="middle" >&lt;0.3 ml/kg/h during 24 h or anuria since 12 h</td></tr><tr><td align="center" valign="middle" >Loss</td><td align="center" valign="middle" >Persisting failure &gt;4 weeks</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >End stage</td><td align="center" valign="middle" >Persisting failure &gt;3 months</td><td align="center" valign="middle" >-</td></tr></tbody></table></table-wrap></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Frequency</title><p>Of the 18,952 children hospitalized during the reporting period, 253 were hospitalized for an ARF (1.3%). This frequency was 2.5% in the pediatric intensive care unit (n = 161/6351), 1.1% in the older children department (n = 58/5263) and 0.5% in the Infant pediatrics (n = 34/7338).</p><p>Socio-demographic characteristics of the study population</p><p>These were children with a mean age of 71.5 &#177; 67.1 months (1 and 204 months). There were 145 boys (57.3%) and 108 girls (42.7%), sex ratio 1.3. They lived in urban areas in 238 cases (94.1%), semi-urban in three cases (1.2%) and rural in 12 cases (4.7%). They came from home with no history of prior consultation in 122 cases (48.2%), with history of prior consultation in a level II hospital in 98 cases (38.7%), with history of prior consultation in a medical office in 21 cases (8.3%) and prior consultation in a Level I Medical Center in 12 cases (4.8%)</p><p>The parents had an average age of 32.7 &#177; 7.9 years old (15 to 58 years old) for the mothers versus 38.9 &#177; 8.9 (19 to 65 years old) for the fathers. They were over 35 years old in 274 cases (63.9%), between 18 and 35 years old in 155 cases (36.1%) and under 18 years old in 3 cases (0.7%). Their level of education was secondary in 240 cases (55.6%), primary in 137 cases (31.7%), higher in 47 cases (10.9%) and in eight cases (1.8%) they had no education. They were unemployed in 158 cases (36.6%), informal sector workers in 132 cases (30.5%), civil servants in 65 cases (15%), workers in 56 cases (13%) and senior executives in 21 cases (4.9%).</p><p>The socio-economic level specified in 220 cases (87%), was low in 135 cases (61.4%), average in 64 cases (29.1%) and high in 21 cases (9.5%).</p></sec><sec id="s3_2"><title>3.2. Anamnestic Data</title><p>The mean time from onset of symptoms to hospitalization was 8.1 &#177; 10.1 days (range 1 to 60 days).</p><p>The treatment administered before hospitalization, in 191 cases (75.5%) was made of plant decoction in four cases (2.1%) and drugs in 187 cases (97.9%). The drugs were nephrotoxic in 42 cases (22.5%), non-steroidal anti-inflammatory drugs in 31 cases and aminoside in 11 cases. These drugs were obtained over-the-counter in 92 cases (49.2%) on prescription of nurses in 59 cases (31.5%) and doctors 36 cases (19.3%).</p></sec><sec id="s3_3"><title>3.3. Clinical Data</title><p>The symptoms leading to hospitalization and those found on the examination are recorded in <xref ref-type="table" rid="table2">Table 2</xref> and <xref ref-type="table" rid="table3">Table 3</xref>.</p></sec><sec id="s3_4"><title>3.4. Para-Clinical Data</title><p>The mean serum creatinine level was 280.5 μmol/l &#177; 262 μmol/l (132.8 μmol/l to 1839.03 μmol/l); the blood urea level was 1.4 &#177; 0.8 g/l (0.3 g/l to 4.1 g/l). In 36</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Motive of hospitalization</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Motives</th><th align="center" valign="middle" >n</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >Respiratory distress</td><td align="center" valign="middle" >78</td><td align="center" valign="middle" >30.8</td></tr><tr><td align="center" valign="middle" >Hypodynamia</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" >22.1</td></tr><tr><td align="center" valign="middle" >Convulsions</td><td align="center" valign="middle" >51</td><td align="center" valign="middle" >20.1</td></tr><tr><td align="center" valign="middle" >Severe anemia</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >8.3</td></tr><tr><td align="center" valign="middle" >Coma</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >6</td></tr><tr><td align="center" valign="middle" >Severe dehydration</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >3.5</td></tr><tr><td align="center" valign="middle" >Hematuria</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >2.4</td></tr><tr><td align="center" valign="middle" >Abdominal pain</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >2</td></tr><tr><td align="center" valign="middle" >Renal edema</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >1.6</td></tr><tr><td align="center" valign="middle" >Renal failure*</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >1.6</td></tr><tr><td align="center" valign="middle" >Anuria</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >1.2</td></tr><tr><td align="center" valign="middle" >Burn</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.4</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >253</td><td align="center" valign="middle" >100.0</td></tr></tbody></table></table-wrap><p>Renal failure*: referred patients.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Examination</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Signs</th><th align="center" valign="middle" >n</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >Fever</td><td align="center" valign="middle" >203</td><td align="center" valign="middle" >80.2</td></tr><tr><td align="center" valign="middle" >Dehydration</td><td align="center" valign="middle" >134</td><td align="center" valign="middle" >52.9</td></tr><tr><td align="center" valign="middle" >Severe</td><td align="center" valign="middle" >119</td><td align="center" valign="middle" >88.8</td></tr><tr><td align="center" valign="middle" >Moderate</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >11.2</td></tr><tr><td align="center" valign="middle" >Pallor</td><td align="center" valign="middle" >108</td><td align="center" valign="middle" >42.7</td></tr><tr><td align="center" valign="middle" >Coma</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >39.5</td></tr><tr><td align="center" valign="middle" >Deep</td><td align="center" valign="middle" >63</td><td align="center" valign="middle" >63</td></tr><tr><td align="center" valign="middle" >Mild</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >37</td></tr><tr><td align="center" valign="middle" >Oliguria/anuria</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >23.7</td></tr><tr><td align="center" valign="middle" >Undernutrition</td><td align="center" valign="middle" >59</td><td align="center" valign="middle" >23.3</td></tr><tr><td align="center" valign="middle" >Blood pressure</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >10.7</td></tr><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >51.9</td></tr><tr><td align="center" valign="middle" >HBP</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >44.4</td></tr><tr><td align="center" valign="middle" >Hypotension</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.7</td></tr><tr><td align="center" valign="middle" >Edema</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >7.5</td></tr><tr><td align="center" valign="middle" >Hemoglobinuria</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >7.5</td></tr><tr><td align="center" valign="middle" >Distended bladder</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >2.4</td></tr><tr><td align="center" valign="middle" >Congestive heart failure</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >2</td></tr><tr><td align="center" valign="middle" >Hypogastric mass</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.4</td></tr></tbody></table></table-wrap><p>NB: these symptoms could be isolated or associated.</p><p>cases, mean serum sodium concentration was 138.2 &#177; 12.8 meq/l (110.7 meq/l to 195.0 meq/l) in 127 cases, hyponatremia in 32 (25.2%), hyper-natremia in 18 cases (14.2%), an average serum potassium concentration of 5.0 &#177; 2.4 meq/l (1.35 meq/l and 12.20 meq/l). Hypokalemia in 27 cases (21.2%), hyperkalemia in 33 cases (26%).</p><p>The serum calcemia performed in three (1.2%) cases were normal; anemia was noted in 112 cases (44.3%) with an average hemoglobin level of 8.6 &#177; 3.1 g/dl (2.9 g/dl to 15 g/dl).</p><p>The urine test strips in 29 cases (11.5%) showed nitrite positivity in 21 cases (72.4%), leukocyturia in 21 cases (72.4%), positive proteinuria in 13 cases (44.2%). ketonuria and positive glycosuria in four cases (13.8).</p><p>The UCBE performed in 19 cases (7.5%), was positive in 8 cases (42.1%). The isolated organisms were E. coli in four cases (50%), Klebsiella pneumoniae SPP in three cases (25%), enterobacterium SPP in one case (12.5%) and staphylococcus aureus in one case (12.5%).</p><p>The 24-hour proteinuria performed in 15 cases (5.9%) was positive in 7 cases (46.7%).</p><p>Blood culture in six cases was positive in three cases. The isolated organisms were Enterobacter Cloacae, Klebsiella, Pseudomonas Fluorescens in one case each.</p><p>The renal ultrasound performed in 41 cases (16.2%), showed: a kidney of normal morphology in 28 cases (68.3%), a kidney of increased size in six cases including five cases with a normal echogenicity and a case with poor corticomedullary differentiation, posterior urethral valves in five cases, bilateral hydronephrosis, bladder and ureteral duplication, and an intravesical expansive process in one case each.</p><p>The chest X-ray performed in 38 cases (15.0%) noted cardiomegaly with signs of overload in four cases, pleural effusion in three cases, alveolar opacity in 13 cases, and interstitial opacity in 18 cases.</p><p>Bicarbonates, blood gases, haptoglobin, C3 complement, coombs test, ECG, PRB were not performed.</p></sec><sec id="s3_5"><title>3.5. Type and Causes of ARF</title><p>The ARF was at failure stage in 147 (58.1%), injury stage in 81 cases (32%) and risk stage in 25 cases (9.9%). The ARF was functional in 210 cases (83%), parenchymal in 34 cases (13.4%) and obstructive in nine cases (3.6%).</p><p>The causes of ARF are shown in <xref ref-type="table" rid="table4">Table 4</xref>.</p></sec></sec><sec id="s4"><title>4. Treatment</title><p>The treatment was conservative and function of etiology in all cases. Hemodialysis was indicated and not performed in 63 cases.</p><sec id="s4_1"><title>4.1. Evolution</title><p>A full recovery was noted in 168 cases (65.6%) and one death in 87 (34.4%) (<xref ref-type="table" rid="table5">Table 5</xref>).</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Causes of renal failure</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"  >Variables</th><th align="center" valign="middle" >n</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle"  rowspan="11"  >Etiologies of functional ARF N = 210 (83.0%)</td><td align="center" valign="middle" >True hypovolemia Severe dehydration</td><td align="center" valign="middle" >121 120</td><td align="center" valign="middle" >57.6 99.2</td></tr><tr><td align="center" valign="middle" >Acute gastroenteritis</td><td align="center" valign="middle" >115</td><td align="center" valign="middle" >95.8</td></tr><tr><td align="center" valign="middle" >Ketoacidosis</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >3.3</td></tr><tr><td align="center" valign="middle" >Burn</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.8</td></tr><tr><td align="center" valign="middle" >Gastrointestinal bleeding</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.8</td></tr><tr><td align="center" valign="middle" >False-positive hypovolemia</td><td align="center" valign="middle" >89</td><td align="center" valign="middle" >42.4</td></tr><tr><td align="center" valign="middle" >Severe malaria</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >64.0</td></tr><tr><td align="center" valign="middle" >Severe sepsis</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >24.9</td></tr><tr><td align="center" valign="middle" >Severe heart failure</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >3.4</td></tr><tr><td align="center" valign="middle" >impure nephrotic syndrome</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >7.9</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >210</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle"  rowspan="7"  >Etiologies of parenchymal ARF N = 34 (13.4%)</td><td align="center" valign="middle" >Acute tubular necrosis</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >41.1</td></tr><tr><td align="center" valign="middle" >Toxic</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >66.7</td></tr><tr><td align="center" valign="middle" >Ischemic</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >33.3</td></tr><tr><td align="center" valign="middle" >Pyelonephritis</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >41.2</td></tr><tr><td align="center" valign="middle" >Acute glomerulonephritis*** post infectious</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >8.8</td></tr><tr><td align="center" valign="middle" >Hemolytic and Uremic Syndrome</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >5.8</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle"  rowspan="5"  >Etiologies of obstructive ARF N = 9 (3.5%)</td><td align="center" valign="middle" >Posterior urethral valves</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >55.6</td></tr><tr><td align="center" valign="middle" >Post-traumatic urethral stenosis</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >22.2</td></tr><tr><td align="center" valign="middle" >Bladder tumor</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >11.1</td></tr><tr><td align="center" valign="middle" >Idiopathic bilateral hydronephrosis</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >11.1</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Distribution of deceased children by age group and by cause</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Age (months) Cause of death/age group</th><th align="center" valign="middle" >1 - 36 n (%)</th><th align="center" valign="middle" >37 - 60 n (%)</th><th align="center" valign="middle" >61 - 120 n (%)</th><th align="center" valign="middle" >121 - 204 n (%)</th><th align="center" valign="middle" >Total n (%)</th></tr></thead><tr><td align="center" valign="middle" >Hypovolemic shock/electrolyte disorder</td><td align="center" valign="middle" >46 (86.8)</td><td align="center" valign="middle" >1 (1.9)</td><td align="center" valign="middle" >2 (3.7)</td><td align="center" valign="middle" >4 (7.5)</td><td align="center" valign="middle" >53 (100)</td></tr><tr><td align="center" valign="middle" >Severe sepsis</td><td align="center" valign="middle" >7 (46.7)</td><td align="center" valign="middle" >2 (13.3)</td><td align="center" valign="middle" >3 (20)</td><td align="center" valign="middle" >3 (20)</td><td align="center" valign="middle" >15 (100)</td></tr><tr><td align="center" valign="middle" >Severe malaria</td><td align="center" valign="middle" >3 (23.1)</td><td align="center" valign="middle" >3 (23.1)</td><td align="center" valign="middle" >3 (23.1)</td><td align="center" valign="middle" >4 (30.7)</td><td align="center" valign="middle" >13 (100)</td></tr><tr><td align="center" valign="middle" >Cardiogenic shock</td><td align="center" valign="middle" >1 (33.3)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >1 (33.3)</td><td align="center" valign="middle" >1 (33.3)</td><td align="center" valign="middle" >3 (100)</td></tr><tr><td align="center" valign="middle" >Septic shock</td><td align="center" valign="middle" >1 (50)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >1 (50)</td><td align="center" valign="middle" >2 (100)</td></tr><tr><td align="center" valign="middle" >Hypertensive encephalopathy</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >1 (100)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >1 (100)</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >58 (66.7)</td><td align="center" valign="middle" >7 (8.1)</td><td align="center" valign="middle" >9 (10.3)</td><td align="center" valign="middle" >13 (14.9)</td><td align="center" valign="middle" >87 (100)</td></tr></tbody></table></table-wrap><p>Mean hospital stay was 7.8 &#177; 9.6 days (range 1 and 68 days) (<xref ref-type="table" rid="table5">Table 5</xref>).</p></sec><sec id="s4_2"><title>4.2. Risk Factors for Mortality</title><sec id="s4_2_1"><title>4.2.1. Unified Analysis</title><p>Relationship between socio-demographic Characteristics and mortality: <xref ref-type="table" rid="table6">Table 6</xref>.</p><p>The young age of the children, the facility of reference and low socioeconomic level of the parents have been identified as risk factor for death.</p><p>Relationship between clinical data and mortality: <xref ref-type="table" rid="table7">Table 7</xref>.</p><p>Relationship between para-clinical data and mortality: <xref ref-type="table" rid="table8">Table 8</xref>.</p></sec><sec id="s4_2_2"><title>4.2.2. Multi-Varied Analysis</title><p>Relationship between mortality and socio-demographic characteristics: <xref ref-type="table" rid="table9">Table 9</xref>.</p><p>Relationship between evolutionary data and mortality: <xref ref-type="table" rid="table1">Table 1</xref>0.</p><p>Relationship between mortality and clinical characteristics are recorded in <xref ref-type="table" rid="table1">Table 1</xref>1.</p><p>Evolutionary characteristics: <xref ref-type="table" rid="table1">Table 1</xref>2.</p><p>The existence of a current complication of hospitalization, the non-completion of hemodialysis and short hospital stay were risk factors for death.</p></sec></sec></sec><sec id="s5"><title>5. Discussion</title><p>The purpose of this study was to improve the management of children with ARF hospitalized at the Brazzaville University Hospital, and to describe epidemiological aspects, identify the causes, describe the evolutionary profile and identify the factors associated with death. This study, although hospital and mono-centric, has the advantage of being carried out in the only Pediatric Intensive Care Unit in Brazzaville. But, it presents some pitfalls; the most important is the retrospective nature of the study source of bias, lost sight of but also in the collection of</p><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Relationship between socio-demographic characteristics and mortality</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Variables</th><th align="center" valign="middle" ></th><th align="center" valign="middle"  colspan="2"  >Death</th><th align="center" valign="middle"  rowspan="2"  >OR</th><th align="center" valign="middle"  rowspan="2"  >CI</th><th align="center" valign="middle"  rowspan="2"  >Khi2</th><th align="center" valign="middle"  rowspan="2"  >p</th></tr></thead><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Yes n (%)</td><td align="center" valign="middle" >No n (%)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Age (months)</td><td align="center" valign="middle" >&lt;60</td><td align="center" valign="middle" >63 (72.4)</td><td align="center" valign="middle" >80 (48.2)</td><td align="center" valign="middle"  rowspan="2"  >2.8</td><td align="center" valign="middle"  rowspan="2"  >1.6 - 4.9</td><td align="center" valign="middle"  rowspan="2"  >13.627</td><td align="center" valign="middle"  rowspan="2"  >0.0001</td></tr><tr><td align="center" valign="middle" >&gt;60</td><td align="center" valign="middle" >24 (27.6)</td><td align="center" valign="middle" >86 (51.8)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Sex</td><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >42 (48.3)</td><td align="center" valign="middle" >66 (39.8)</td><td align="center" valign="middle"  rowspan="2"  >1.694</td><td align="center" valign="middle"  rowspan="2"  >0.8 - 2.3</td><td align="center" valign="middle"  rowspan="2"  >1.4</td><td align="center" valign="middle"  rowspan="2"  >0.193</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >45 (51.7)</td><td align="center" valign="middle" >100 (60.2)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Provenance</td><td align="center" valign="middle" >Health facility</td><td align="center" valign="middle" >63 (72.4)</td><td align="center" valign="middle" >68 (41)</td><td align="center" valign="middle"  rowspan="2"  >3.8</td><td align="center" valign="middle"  rowspan="2"  >2.1 - 6.6</td><td align="center" valign="middle"  rowspan="2"  >22.613</td><td align="center" valign="middle"  rowspan="2"  >0.0001</td></tr><tr><td align="center" valign="middle" >Home</td><td align="center" valign="middle" >24 (27.6)</td><td align="center" valign="middle" >98 (51)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Socioeconomic status</td><td align="center" valign="middle" >Bas</td><td align="center" valign="middle" >61 (70.1)</td><td align="center" valign="middle" >74 (44.6)</td><td align="center" valign="middle"  rowspan="2"  >3.7</td><td align="center" valign="middle"  rowspan="2"  >2.1 - 5.9</td><td align="center" valign="middle"  rowspan="2"  >22.419</td><td align="center" valign="middle"  rowspan="2"  >0.0001</td></tr><tr><td align="center" valign="middle" >Other</td><td align="center" valign="middle" >26 (29.9)</td><td align="center" valign="middle" >92 (54.4)</td></tr><tr><td align="center" valign="middle" >Duration of symptoms before admission</td><td align="center" valign="middle" >&gt;7</td><td align="center" valign="middle" >21 (24.1)</td><td align="center" valign="middle" >37 (22.3)</td><td align="center" valign="middle" >1.1</td><td align="center" valign="middle" >0.6 - 2</td><td align="center" valign="middle" >0.110</td><td align="center" valign="middle" >0.739</td></tr><tr><td align="center" valign="middle" >(Days)</td><td align="center" valign="middle" >&lt;7</td><td align="center" valign="middle" >66 (75.9)</td><td align="center" valign="middle" >129 (77.7)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><table-wrap id="table7" ><label><xref ref-type="table" rid="table7">Table 7</xref></label><caption><title> Relationship between clinical data and mortality</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="3"   rowspan="2"  >Signs</th><th align="center" valign="middle"  colspan="2"  >Overall evolution</th><th align="center" valign="middle"  rowspan="2"  >Khi 2</th><th align="center" valign="middle"  rowspan="2"  >OR</th><th align="center" valign="middle"  rowspan="2"  >CI</th><th align="center" valign="middle"  rowspan="2"  >P</th></tr></thead><tr><td align="center" valign="middle" >Death n (%)</td><td align="center" valign="middle" >Favorable n (%)</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Dehydration</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  rowspan="2"  ></td><td align="center" valign="middle"  colspan="2"  >Severe</td><td align="center" valign="middle" >41 (34.5)</td><td align="center" valign="middle" >78 (65.5)</td><td align="center" valign="middle"  rowspan="3"  >4.517</td><td align="center" valign="middle"  rowspan="3"  >2.6</td><td align="center" valign="middle"  rowspan="3"  >1.04 - 6.3</td><td align="center" valign="middle"  rowspan="2"  >0.001</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Moderate</td><td align="center" valign="middle" >1 (6.7)</td><td align="center" valign="middle" >14 (93.3)</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Coma</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  >Deep</td><td align="center" valign="middle" >42 (66.7)</td><td align="center" valign="middle" >21 (33.3)</td><td align="center" valign="middle"  rowspan="3"  >10.635</td><td align="center" valign="middle"  rowspan="3"  >4.1</td><td align="center" valign="middle"  rowspan="3"  >1.7 - 9.7</td><td align="center" valign="middle"  rowspan="3"  >0.0001</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  >Mild</td><td align="center" valign="middle" >13 (35.1)</td><td align="center" valign="middle" >24 (64.9)</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Diuresis</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  >Oliguria/anuria</td><td align="center" valign="middle" >45 (75)</td><td align="center" valign="middle" >15 (25)</td><td align="center" valign="middle"  rowspan="2"  >57.497</td><td align="center" valign="middle"  rowspan="2"  >10.8</td><td align="center" valign="middle"  rowspan="2"  >5.4 - 21.2</td><td align="center" valign="middle"  rowspan="2"  >0.0001</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  >Preserved</td><td align="center" valign="middle" >42 (21.8)</td><td align="center" valign="middle" >151 (78.2)</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Nutritional status</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"   rowspan="2"  ></td><td align="center" valign="middle" >Undernutrition</td><td align="center" valign="middle" >34 (57.6)</td><td align="center" valign="middle" >25 (42.4)</td><td align="center" valign="middle"  rowspan="2"  >18.218</td><td align="center" valign="middle"  rowspan="2"  >3.6</td><td align="center" valign="middle"  rowspan="2"  >1.9 - 6.6</td><td align="center" valign="middle"  rowspan="2"  >0.0001</td></tr><tr><td align="center" valign="middle" >Eutrophic</td><td align="center" valign="middle" >53 (27.3)</td><td align="center" valign="middle" >141 (72.7)</td></tr><tr><td align="center" valign="middle"  colspan="3"  >ARF stage</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"   rowspan="2"  ></td><td align="center" valign="middle" >Failure</td><td align="center" valign="middle" >64 (43.5)</td><td align="center" valign="middle" >83 (56.5)</td><td align="center" valign="middle"  rowspan="2"  >13.019</td><td align="center" valign="middle"  rowspan="2"  >2.8</td><td align="center" valign="middle"  rowspan="2"  >1.5 - 4.9</td><td align="center" valign="middle"  rowspan="2"  >0.0001</td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >23 (21.7)</td><td align="center" valign="middle" >83 (78.3)</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Type of ARF</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"   rowspan="2"  ></td><td align="center" valign="middle" >Functional</td><td align="center" valign="middle" >75 (35.7)</td><td align="center" valign="middle" >135 (64.3)</td><td align="center" valign="middle"  rowspan="2"  >0.964</td><td align="center" valign="middle"  rowspan="2"  >1.4</td><td align="center" valign="middle"  rowspan="2"  >0.7 - 2.9</td><td align="center" valign="middle"  rowspan="2"  >0.326</td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >12 (27.9)</td><td align="center" valign="middle" >31(72.1)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><table-wrap id="table8" ><label><xref ref-type="table" rid="table8">Table 8</xref></label><caption><title> Relationship between paraclinical data and death</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"   rowspan="2"  >Biological parameters</th><th align="center" valign="middle"  rowspan="2"  >Frequency (%)</th><th align="center" valign="middle"  rowspan="2"  >Mean</th><th align="center" valign="middle"  colspan="4"  >Student test</th></tr></thead><tr><td align="center" valign="middle" >Average difference</td><td align="center" valign="middle" >t</td><td align="center" valign="middle" >Bilateral significance</td><td align="center" valign="middle" >CI</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Urea</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  rowspan="2"  ></td><td align="center" valign="middle" >Death</td><td align="center" valign="middle" >15 (41.7)</td><td align="center" valign="middle" >1.5</td><td align="center" valign="middle"  rowspan="2"  >0.18</td><td align="center" valign="middle"  rowspan="2"  >0.6</td><td align="center" valign="middle"  rowspan="2"  >0.525</td><td align="center" valign="middle"  rowspan="2"  >−5.7; 9.7</td></tr><tr><td align="center" valign="middle" >Living</td><td align="center" valign="middle" >21 (58.3)</td><td align="center" valign="middle" >1.3</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Creatinine</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  rowspan="2"  ></td><td align="center" valign="middle" >Death</td><td align="center" valign="middle" >87 (34.4)</td><td align="center" valign="middle" >32.9</td><td align="center" valign="middle"  rowspan="2"  >1.9</td><td align="center" valign="middle"  rowspan="2"  >0.5</td><td align="center" valign="middle"  rowspan="2"  >0.614</td><td align="center" valign="middle"  rowspan="2"  >−5.6; 9.6</td></tr><tr><td align="center" valign="middle" >Living</td><td align="center" valign="middle" >166 (65.6)</td><td align="center" valign="middle" >31</td></tr></tbody></table></table-wrap><p>data. Thus, the results of this study can be extrapolated to the entire child population of Brazzaville. It worth to be done specially since there is only pediatric intensive care unit in Brazzaville. But, there are some pitfalls, the first of which is related to the mono-centric character and the second due to the retrospective nature of this study, sources of bias in lost-to-follow-up.</p><p>The prevalence of pediatric ARF varies from one country to the other depending</p><table-wrap id="table9" ><label><xref ref-type="table" rid="table9">Table 9</xref></label><caption><title> Relationship between mortality and sociodemographic characteristics</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Khi2</th><th align="center" valign="middle" >OR</th><th align="center" valign="middle" >IC</th><th align="center" valign="middle" >p</th><th align="center" valign="middle" >ORa</th><th align="center" valign="middle" >CI</th><th align="center" valign="middle" >P</th></tr></thead><tr><td align="center" valign="middle" >Age &lt; 60 months</td><td align="center" valign="middle" >13.627</td><td align="center" valign="middle" >2.8</td><td align="center" valign="middle" >1.6 - 4.9</td><td align="center" valign="middle" >0.0001</td><td align="center" valign="middle"  rowspan="2"  >2.2</td><td align="center" valign="middle"  rowspan="2"  >1.7 - 2.9</td><td align="center" valign="middle"  rowspan="2"  >0.000</td></tr><tr><td align="center" valign="middle" >Health facility</td><td align="center" valign="middle" >22.613</td><td align="center" valign="middle" >3.8</td><td align="center" valign="middle" >2.1 - 6.6</td><td align="center" valign="middle" >0.0001</td></tr><tr><td align="center" valign="middle" >Low socio-economic level</td><td align="center" valign="middle" >22.419</td><td align="center" valign="middle" >3.7</td><td align="center" valign="middle" >2.1 - 5.9</td><td align="center" valign="middle" >0.0001</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><table-wrap id="table10" ><label><xref ref-type="table" rid="table1">Table 1</xref>0</label><caption><title> Relationship between evolution and mortality</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"   rowspan="2"  ></th><th align="center" valign="middle"  colspan="2"  >Overall evolution</th><th align="center" valign="middle"  rowspan="2"  >Khi 2</th><th align="center" valign="middle"  rowspan="2"  >OR</th><th align="center" valign="middle"  rowspan="2"  >CI</th><th align="center" valign="middle"  rowspan="2"  >P</th></tr></thead><tr><td align="center" valign="middle" >Deaths n (%)</td><td align="center" valign="middle" >Favorable n (%)</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Complications</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  rowspan="2"  ></td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >64 (63.4)</td><td align="center" valign="middle" >37 (36.6)</td><td align="center" valign="middle"  rowspan="2"  >33.113</td><td align="center" valign="middle"  rowspan="2"  >5.5</td><td align="center" valign="middle"  rowspan="2"  >2.9 - 10.1</td><td align="center" valign="middle"  rowspan="2"  >0.0001</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >23 (15.1)</td><td align="center" valign="middle" >129 (84.9)</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Indication of dialysis</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  rowspan="2"  ></td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >47 (54.0)</td><td align="center" valign="middle" >16 (9.6)</td><td align="center" valign="middle"  rowspan="2"  >60.133</td><td align="center" valign="middle"  rowspan="2"  >11</td><td align="center" valign="middle"  rowspan="2"  >5.7 - 21.4</td><td align="center" valign="middle"  rowspan="2"  >0.0001</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >40 (46.0)</td><td align="center" valign="middle" >150 (90.4)</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Hospital stay</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  rowspan="2"  ></td><td align="center" valign="middle" >&lt;7</td><td align="center" valign="middle" >74 (45.4)</td><td align="center" valign="middle" >89 (54.6)</td><td align="center" valign="middle"  rowspan="2"  >25.109</td><td align="center" valign="middle"  rowspan="2"  >5.2</td><td align="center" valign="middle"  rowspan="2"  >2.6 - 10.3</td><td align="center" valign="middle"  rowspan="2"  >0.0001</td></tr><tr><td align="center" valign="middle" >&gt;7</td><td align="center" valign="middle" >15 (16.7)</td><td align="center" valign="middle" >75 (83.3)</td></tr></tbody></table></table-wrap><table-wrap id="table11" ><label><xref ref-type="table" rid="table1">Table 1</xref>1</label><caption><title> Relationship between death and clinical findings</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Khi 2</th><th align="center" valign="middle" >OR</th><th align="center" valign="middle" >CI</th><th align="center" valign="middle" >p</th><th align="center" valign="middle" >ORa</th><th align="center" valign="middle" >CI</th><th align="center" valign="middle" >p</th></tr></thead><tr><td align="center" valign="middle" >Deep coma</td><td align="center" valign="middle" >10.635</td><td align="center" valign="middle" >4.1</td><td align="center" valign="middle" >1.7-9.7</td><td align="center" valign="middle" >0.0001</td><td align="center" valign="middle"  rowspan="5"  >2.3</td><td align="center" valign="middle"  rowspan="5"  >1.9 - 2.6</td><td align="center" valign="middle"  rowspan="5"  >0.0001</td></tr><tr><td align="center" valign="middle" >Severe dehydration</td><td align="center" valign="middle" >4.517</td><td align="center" valign="middle" >2.6</td><td align="center" valign="middle" >1.04-6.3</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >Undernutrition</td><td align="center" valign="middle" >18.218</td><td align="center" valign="middle" >3.6</td><td align="center" valign="middle" >1.9-6.6</td><td align="center" valign="middle" >0.0001</td></tr><tr><td align="center" valign="middle" >Oliguria/anuria</td><td align="center" valign="middle" >57.497</td><td align="center" valign="middle" >10.8</td><td align="center" valign="middle" >5.4-21.2</td><td align="center" valign="middle" >0.0001</td></tr><tr><td align="center" valign="middle" >Failure stage ARF</td><td align="center" valign="middle" >13.019</td><td align="center" valign="middle" >2.8</td><td align="center" valign="middle" >1.5-4.9</td><td align="center" valign="middle" >0.0001</td></tr></tbody></table></table-wrap><table-wrap id="table12" ><label><xref ref-type="table" rid="table1">Table 1</xref>2</label><caption><title> Relationship between mortality and therapeutic and evolutionary characteristics</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Khi2</th><th align="center" valign="middle" >OR</th><th align="center" valign="middle" >CI</th><th align="center" valign="middle" >p</th><th align="center" valign="middle" >ORa</th><th align="center" valign="middle" >IC</th><th align="center" valign="middle" >p</th></tr></thead><tr><td align="center" valign="middle" >Complications</td><td align="center" valign="middle" >33.113</td><td align="center" valign="middle" >5.5</td><td align="center" valign="middle" >2.9 - 10.1</td><td align="center" valign="middle" >0.0001</td><td align="center" valign="middle"  rowspan="3"  >3.1</td><td align="center" valign="middle"  rowspan="3"  >2.5 - 3.8</td><td align="center" valign="middle"  rowspan="3"  >0.0001</td></tr><tr><td align="center" valign="middle" >Absence dialysis</td><td align="center" valign="middle" >60.133</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >5.7 - 21.4</td><td align="center" valign="middle" >0.0001</td></tr><tr><td align="center" valign="middle" >Hospital stay &lt;7 days</td><td align="center" valign="middle" >25.109</td><td align="center" valign="middle" >5.2</td><td align="center" valign="middle" >2.6 - 10.3</td><td align="center" valign="middle" >0.0001</td></tr></tbody></table></table-wrap><p>on methodological differences and the level of health facility. The available data are essentially those of multicenter surveys. Its prevalence is 1.3% in this study as in that of Assounga [<xref ref-type="bibr" rid="scirp.95512-ref12">12</xref>] in the same hospital. Similar prevalence is reported by Keita in Senegal and Ifeoma in Nigeria [<xref ref-type="bibr" rid="scirp.95512-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref10">10</xref>] respectively 0.91% and 1.0%. Higher prevalence is noted in the work done in the DRC, Algeria, Nigeria, Burkina Faso and Brazil [<xref ref-type="bibr" rid="scirp.95512-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref19">19</xref>] with respective rates of 1.78%, 3.07%, 3.13%, 3.3%, and 8%. In contrast, those in China and the United States report low prevalence of 0.32% and 0.39 [<xref ref-type="bibr" rid="scirp.95512-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref20">20</xref>] . These disparities can be explained, among other things, by the delay in consultation and, in particular, the management of ARF etiologies in developing countries.</p><p>The age of onset varies from one study to another and is a function of the target population. It is on average 71.5 &#177; 67 months in our study as described in the works of Gheissari, Ifeoma, Batouche and Bunchman [<xref ref-type="bibr" rid="scirp.95512-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref22">22</xref>] . In Senegal, Burkina Faso, Pakistan and the United States the average age varies between 80.4 and 129.6 months [<xref ref-type="bibr" rid="scirp.95512-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref23">23</xref>] . Younger children from 12.79 to 67.2 months are the most reported in the works of Riyuzoa, Abdullah, Oubella, Moghtaderi, Shalaby, Moussa Ntondi, Cao and Damte Shimelis [<xref ref-type="bibr" rid="scirp.95512-ref24">24</xref>] - [<xref ref-type="bibr" rid="scirp.95512-ref30">30</xref>] .</p><p>The male predominance noted in the literature [<xref ref-type="bibr" rid="scirp.95512-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref31">31</xref>] is found in this study without any significant difference.</p><p>The reasons for consultation and the revealing symptoms are also variable from one study to another, depending on the etiology and the existence of complications relating to delay in consultation [<xref ref-type="bibr" rid="scirp.95512-ref29">29</xref>] . The predominant symptoms are: respiratory distress, hypodynamic, convulsions, fever, oligoanuria [<xref ref-type="bibr" rid="scirp.95512-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref32">32</xref>] - [<xref ref-type="bibr" rid="scirp.95512-ref37">37</xref>] . The definitive diagnosis is provided by creatinine, which has been significantly contributive to this study.</p><p>Diagnosis is made at the stage of renal failure (58.1%) as in Halle works 86.2% [<xref ref-type="bibr" rid="scirp.95512-ref38">38</xref>] , Oubella 81% [<xref ref-type="bibr" rid="scirp.95512-ref26">26</xref>] , Jakanattane 35.9% [<xref ref-type="bibr" rid="scirp.95512-ref35">35</xref>] , Duzova 43.0% [<xref ref-type="bibr" rid="scirp.95512-ref34">34</xref>] , Tresa 76.7% [<xref ref-type="bibr" rid="scirp.95512-ref23">23</xref>] , Riyuzo 94.8% [<xref ref-type="bibr" rid="scirp.95512-ref24">24</xref>] and Batouche [<xref ref-type="bibr" rid="scirp.95512-ref18">18</xref>] . In China and Saudi Arabia, the risk stage predominates [<xref ref-type="bibr" rid="scirp.95512-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref28">28</xref>] .</p><p>In terms of etiologies, the predominance of severe dehydration in the occurrence of functional ARF of the child is a known fact [<xref ref-type="bibr" rid="scirp.95512-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref40">40</xref>] . It was hypovolemic in 83% of cases in this study. Other causes are: severe malaria, the first cause of functional ARF in black Africa [<xref ref-type="bibr" rid="scirp.95512-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref29">29</xref>] , second cause in our study and severe sepsis, whose genesis in the occurrence of functional ARF is well known [<xref ref-type="bibr" rid="scirp.95512-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref33">33</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref35">35</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref38">38</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref39">39</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref40">40</xref>] .</p><p>The evolution of ARF in children is generally favorable [<xref ref-type="bibr" rid="scirp.95512-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref33">33</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref35">35</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref36">36</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref41">41</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref42">42</xref>] . But it can be laced with complications including hyperkalemia, acute pulmonary edema and metabolic acidosis [<xref ref-type="bibr" rid="scirp.95512-ref35">35</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref37">37</xref>] . Its prognosis is depending to the etiology, the speed of management and the level of the health facility and the accessibility to extra-renal purification. The lethality of 34.4%, found in this study is similar to that of Assounga [<xref ref-type="bibr" rid="scirp.95512-ref12">12</xref>] . Lethality varying between 32% and 56.2% are reported in C&#244;te d’Ivoire, Nigeria, Senegal, Saudi Arabia, Morocco, Turkey, Baghdad, Brazil, Nigeria, Thailand, India, in Kuwait, Togo, Cameroon and Lithuania [<xref ref-type="bibr" rid="scirp.95512-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref27">27</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref34">34</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref33">33</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref35">35</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref36">36</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref38">38</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref40">40</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref41">41</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref42">42</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref43">43</xref>] . Lesser lethality is reported in developed and developing countries with extra-renal purification centers [<xref ref-type="bibr" rid="scirp.95512-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref31">31</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref39">39</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref42">42</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref44">44</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref45">45</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref46">46</xref>] .</p><p>The risk factors for death reported in Morocco, Bangladesh, India, Lithuania and Iran [<xref ref-type="bibr" rid="scirp.95512-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref31">31</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref36">36</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref39">39</xref>] [<xref ref-type="bibr" rid="scirp.95512-ref46">46</xref>] are age below five years, provenance of the child, the existence of deep coma, severe dehydration, undernutrition, oligoanuria, ARF at failure stage, lack of dialysis and hospital stay of less than seven days.</p><p>Conclusion</p><p>The ARF of the child is frequent at the University Hospital of Brazzaville. It predominates in children under 36 months and low socioeconomic status. Severe dehydration is the main etiology. High lethality reflects its severity. Young age, provenance of the child, severe dehydration, deep coma, oligoanuria, stage of renal failure and absence of an extra-renal purification center are some of the factors associated with death of inpatient children with ARF.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Moyen, E., Bomelefa-Bomel, V., Ekouya-Bowassa, G., Sinomono, T.E., Oko, A.P.G., Mbolla, B.F.E. and Moyen, G.M. (2019) Acute Renal Failu re in Children at the University Hospital of Brazzaville. Open Journal of Pediatrics, 9, 253-272. https://doi.org/10.4236/ojped.2019.93024</p></sec><sec id="s8"><title>Annex: Survey Sheet</title>I. Identity<p>Last name and first name :…………………………………………………………………</p><p>Age: ............... months 1 - 11 months /_ / 12 - 60 months /_ / 61 - 120 months / _ / 121 - 204 months / _ /</p><p>Sex: M / _ / F / _ /</p><p>Adress (of the child):</p><p>&#183; BZV: Yes / _ / No / _ /</p><p>o Makelekele / _ / Bacongo / _ / Poto-poto / _ / Moungali / _ / Ouenze / _ /</p><p>Talangai / _ / MFilou / _ / madibou / _ / Djiri / _ /</p><p>&#183; Other: Yes / _ / No / _ / If yes, specify: ...................................................</p><p>Provenance: Home / _ / Base hospital / _ / Integrated Health center / _ / Doctor’s office / _ /</p><p>Any department of the University Hospital of Brazzaville / _ /</p><p>Specify: ................................................ ..</p><p>Year: 2016 / _ / 2017 / _ / 2018 / _ /</p><p>Month of hospitalization: /..................../</p><p>Hospitalization Service: SIP / _ / PGE / _ / PN / _ /</p><p>Reason for referral or hospitalization: .....................................................</p>II. History of the Disease<p>Duration of symptoms before admission: ...... .. &lt;7 days / _ /; 7 and 14 Days / _ / ≥ 15 Days / _ /</p><p>Duration of symptoms before the first consultation in any health center: ..................</p><p>Interval: &lt;7 days / _ /; 7 and 14 Days / _ / ≥15 Days / _ /</p><p>Symptoms: ...................................................................................................</p>III. Antecedents<p>Personal:</p><p>Uropathy Yes / _ / No / _ / Urolithiasis Yes / _ / No / _ / HTA Yes / _ / No / _ /</p><p>Diabetes Yes / _ / No / _ / Hemoglobinopathies Yes / _ / No / _ / HIV: Yes / _ / No / _ /</p><p>Hematopathy: Yes / _ / No / _ / Nephrotic syndrome: Yes / _ / No / _ / GNA: Yes / _ / No / _ /</p><p>Cardiopathy: Yes / _ / No / _ / Long-term treatment: Yes / _ / No / _ /</p><p>If yes: Folic acid / _ / TAR / _ / Digoxin / _ / Captopril / _ / Iron / _ / corticosteroid / _ /</p><p>Prior medication before hospitalization:</p><p>Treatment given before hospitalization Yes / _ / No / _ /</p><p>If Yes: Medical / _ / Traditional / _ /</p><p>If medical treatment:</p><p>Duration of treatment: &lt;7 days / _ /; 7 and 14 Days / _ / ≥ 15 Days / _ /</p><p>ATB: aminoglycoside /C3G / metronidazole / quinolone / Amoxi + ac clav / /</p><p>Amoxicillin / _ / macrolide / _ / cotrimoxazole / _ /</p><p>Antipalust: A + L / _ / quinine / _ / arthemether / _ / artesunate / _ /</p><p>NSAID / _ / corticosteroid / _ / diazepam / _ / diarrhea / /</p><p>Specify the delay between taking the medication and hospitalization: ..................</p><p>Interval: &lt;7days / _ /; 7 and 14Days / _ / ≥ 15Days / _ /</p><p>Family history:</p><p>Sibling: size ................... Any other disease history ................................................</p><p>Parents:</p><p>&#183; Mother:</p><p>o Age:</p><p>o Level of education: out of school / _ / primary / _ / secondary / _ / higher / _ /</p><p>o Job: .............................................................................</p><p>o Socio-economic level: low / _ / medium / _ / high / _ / not specified / _ /</p><p>o Pathological ATCD: HTA / _ / diabetes / _ / renal patho / _ / DSS / _ / HIV / _ /</p><p>&#183; Father:</p><p>o Age:</p><p>o Level of education: out of school / _ / primary / _ / secondary / _ / higher / _ /</p><p>o Job: ...............................................................................</p><p>o Socio-economic level: low / _ / medium / _ / high / _ / not specified / _ /</p><p>o Pathological ATCD: HTA / _ / diabetes / _ / renal patho / _ / DSS / _ / HIV / _ /</p>IV. Clinical Aspects<p>1. Overall Examination</p><p>Consciousness: normal /_ / coma /_ /; if yes: mild /_ / moderate /_ / deep /_ /</p><p>Pale Yes / _ / No / _ / if yes, specify: .............................................</p><p>Dehydration Yes / _ / No / _ / if yes, specify: .............................................</p><p>Jaundice Yes / _ / No / _ /</p><p>Edema: Yes / _ / No / _ / If yes: Lower limbs / _ / Face / _ / Generalized / _ /</p><p>Diuresis ......... ..ml / h, Anuria / _ / Oligoanuria / _ / Normal / _ / Not specified / _ /</p><p>BP ............... mmHg Normal / _ / HTA / _ / Hypotension / _ / Not specified / _ /</p><p>T˚ ............. ˚C Normal / _ / hyperthermia / _ / hypothermia / _ / Not specified / _ /</p><p>Nutritional status: Eutrophy / _ / Emaciation / _ / Severe E. / _ / Overweight / _ / Not specified / _ /</p><p>2. Physical Examination</p><p>Dyspnoea Yes / _ / No / _ / If yes: Mild / _ / Moderate / _ / Severe / _ / kuss mall / _ /</p><p>Ascitic edematous syndrome Yes / _ / No / _ /</p><p>Ascites Yes / _ / No / _ /</p><p>Lumbar mass Yes / _ / No / _ / if yes: specify the location ............................ ......</p><p>Acute Urine Retention (RAU) Yes / _ / No / _ /</p><p>Heart failure Yes / _ / No / _ /</p><p>if yes: Global heart failure (HF)/ _ / Left-sided HF / _ / Right-sided HF /_ /</p><p>Other signs: ...............................................................................................</p><p>3. Para-Clinical Examinations</p><p>3.1. Biology</p><p>Creatinine: Yes / _ / No / _ /</p><p>Results: 1) ......... .2) ......... 3) .......... 4) ......... 5) ......... 6) ...... ....</p><p>Range: [10-20] / _ / [21-30] / _ / [31-40] / _ / [41-50] / _ / [51-60] / _ / [61-70] / _ / [71-80] / _ / [81-90] / _ / [91-100] / _ / ≥101 / _ /</p><p>Urea: Yes / _ / No / _ / Results: ......... ≤1 / _ / 1-1.99 / _ / 2-2.99 / _ / 3-3.99 / _ / ≥ 4 / _ /</p><p>Uric acid: Yes / _ / No / _ / Results: ................................................................</p><p>Blood Ionogram: Yes / _ / No / _ /</p><p>Sodium ........................ mEq/l normal / _ / hyper natremia / _ / hypo-natremia / _ /</p><p>Potassium ..................... mEq/l normal / _ / hyperkalemia / _ / hypo kaliemia / _ /</p><p>Chlorine ........................ mEq/l normal / _ / hyperchloremia / _ / hypo chloremia / _ /</p><p>Calcium: Yes / _ / No / _ /</p><p>Results: ............... mEq/L. Normal / _ / hypercemia / _ / hypo calcemia / _ /</p><p>Phosphoremia: Yes / _ / No / _ / Normal / _ / high / _ / lower / _ /</p><p>Bicarbonate: Yes / _ / No / _ / Normal / _ / high / _ / lower / _ /</p><p>Hemogram: Yes / _ / No / _ /</p><p>Hb: .............. (g/dl) Normal / _ / A. mild / _ / A. moderate / _ / A. severe / _ /</p><p>WBC ................. Normal / _ / leukocytosis / _ / leukopenia / _ /</p><p>Platelets .......... Normal / _ / thrombocytosis / _ / thrombocytopenia / _ /</p><p>MCV ...... .. ... .. ... .. Normal / _ / high / _ / lower / _ /</p><p>MCH .... ... .. ...... .. Normal / _ / high / _ / lower / _ /</p><p>Blood glucose Yes / _ / No / _ /</p><p>Results: ....... ... g / l Normal / _ / hypoglycemia / _ / hyperglycemia / _ /</p><p>Urine strips Yes / _ / No / _ / Results: ..................................... .......................................</p><p>Leukocyte: Yes / _ / No / _ /, Nitrite: Yes / _ / No / _ /,</p><p>Proteinuria: absent / _ / 1+ / _ / 2+ / _ / 3+ / _ / 4+ / _ /</p><p>Cetonurie: Yes / _ / No / _ / Glucosuria: Yes / _ / No / _ /</p><p>UCBE: Yes / _ / No / _ / Leukocyte: Yes / _ / No / _ /, Nitrite: Yes / _ / No / _ /, germ .........</p><p>Proteinuria of 24 hours: Yes / _ / No / _ / Results: ...... negative /_ / massive /_ / moderate /_ /</p><p>Thick smear: Yes / _ / No / _ /, if yes: positive / _ / negative / _ /</p><p>CRP: Yes / _ / No / _ /, if yes: Normal / _ / high / _ / moderate / _ /</p><p>ESR: Yes / _ / No / _ /, if yes: Normal / _ / high / _ / moderate / _ /</p><p>HIV serology: Yes / _ / No / _ /, if yes: positive / _ / negative / _ /</p><p>Hemoculture: Yes / _ / No / _ /, germ: ..................................... ............ ..</p><p>Coproculture: Yes / _ / No / _ /, germ: ..................................... ............ ..</p><p>3.2. Imaging</p><p>Abdominal X-ray: yes / _ / no / _ / Results: ..............................................................................</p><p>Renal ultrasound yes / _ / no / _ / Results: ...................................................</p><p>Abdominal ultrasound yes / _ / no / _ / Results: ...................................................</p><p>Intravenous Urography: Yes / _ / no / _ / Results: .................................................</p><p>Retrograde urethrocystography yes / _ / no / _ / Results: ..............................................</p><p>Computed tomography: yes / _ / no / _ / Results: .........................................................</p><p>Chest x-ray: yes / _ / no / _ /</p><p>If yes: alveolar images/_ / interstitial images /_ / alveolar-interstitial images/_ /</p><p>Pleural effusion / _ / Left cardiomyopathy / _ /</p><p>4. Discharge Diagnosis................................................................................. ...</p><p>5. IRA classification: stage of risk / _ / stage of injury / _ / stage of failure / _ /</p><p>6. Type of acute renal failure: functional / _ / parenchymatous / _ / obstructive / _ /</p>V. Assumed Causes of ARF<p>Functional ARF: dehydration / _ / anemia / _ / hemorrhage / _ / Burn / _ /</p><p>Impure nephrotic syndrom / _ / sepsis / _ / heart failure / _ /</p><p>Parenchymatous ARF: acute glomerulonephritis/_ / Impure nephrotic syndrom / _ / Haemolytic uraemic syndrome / _ / ATN / _ / Acute Interstitial Nephritis / _ / Urinary tract infection / _ /</p><p>Obstructive ARF: PUV / _ / Ureteral stenosis / _ / Bladder tumor / _ /</p><p>Hydron&#233;phrose / _ / Lithiasis / _ /</p>VI. Treatment Received<p>&#183; Vascular filling: yes / _ / no / _ / if yes: ISS / _ / IGS / _ / LR / _ / gelofusine / _ /</p><p>&#183; Transfusion: yes / _ / no / _ / if yes: PRBC / _ / platelet / _ / FFP / _ /</p><p>&#183; Hyperkalemia treatment: yes / _ / no / _ /</p><p>&#183; if yes: kayexalate / _ / sodium bicarbonate / _ / salbutamol / _ / insulin / _ /</p><p>&#183; Treatment of acidosis: yes / _ / no / _ / if yes: dialysis / _ / bicarbonate / _ /</p><p>&#183; Treatment of hyponatremia: yes / _ / no / _ /</p><p>&#183; if yes, intravenous sodium supplementation / _ / sodium supplementation per os / _ /</p><p>&#183; Treatment of hypocalcemia: yes / _ / no / _ / if yes, calcium supplementation IV / _ /</p><p>&#183; Obstacle lift: yes / _ / no / _ / if yes: vesical cystostomy / _ /</p><p>&#183; vasoactive amine: yes / _ / no / _ / intubation / VA: yes / _ / no / _ /</p><p>&#183; Lasilix: yes / _ / no / _ / IEC: yes / _ / no / _ /</p><p>&#183; Corticoid: yes / _ / no / _ / Immunosuppressive: yes / _ / no / _ /</p><p>&#183; Extra-renal treatment: yes / _ / no / _ /</p><p>&#183; Other to be specified: ..................................................................................</p>VII. Evolution<p>&#183; Overall evolution: Death: / _ / Favorable: / _ /</p><p>o If favorable evolution: Output: / _ / Transfer / _ /</p><p>&#167; If transfer, specify service: ....................................................</p><p>o Renal function at discharge: normal: / _ / ↓ partial / _ / not specified / _ /</p><p>&#183; Complication: yes / _ / no / _ /</p><p>o If yes, specify: ...........................................................................</p><p>&#183; Cause of death: ................................................................................</p><p>Duration of hospitalization: ......... 3 days / _ / 3 and 7 days / _ /&gt; 7 days / _ /</p></sec></body><back><ref-list><title>References</title><ref id="scirp.95512-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Macher, M.A. (2004) Insuffisance rénale aigue chez l’enfant. EMC-Pédiatrie, 1, 73-78. https://doi.org/10.1016/j.emcped.2003.09.004</mixed-citation></ref><ref id="scirp.95512-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Bourquia, A. (2014) Guide Africain de Néphrologie Pédiatrique. IPNA, 216.</mixed-citation></ref><ref id="scirp.95512-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Valette, X., Terzi, N. and du Cheyron, D. (2010) Quelle définition pour l’insuffisance rénale aigue en réanimation? Réanimation, 19, 431-440.  
https://doi.org/10.1016/j.reaurg.2010.04.006</mixed-citation></ref><ref id="scirp.95512-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Jacobs, F.M. and Brivet, F.G. (2005) épidémiologie et pronostic des insuffisances rénales aigues en réanimation. Réanimation, 14, 472-482.  
https://doi.org/10.1016/j.reaurg.2005.09.011</mixed-citation></ref><ref id="scirp.95512-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Moghal, N.E., Brocklebank, J.T. and Meadow, S.R. (1998) A Review of Acute Renal Failure in Children: Incidence, Etiology and Outcome. Clinical Nephrology, 49, 91-95.</mixed-citation></ref><ref id="scirp.95512-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Sutherland, S.M., Ji, J., Sheikhi, F.H., Widen, E., Tian, L., Alexander, S.A., et al. (2013) AKI in Hospitalized Children: Epidemiology and Clinical Associations in a National Cohort. Clinical Journal of the American Society of Nephrology, 8, 1661-1669. https://doi.org/10.2215/CJN.00270113</mixed-citation></ref><ref id="scirp.95512-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Bailey, D., Phan, V., Litalien, C., Ducruet, T., Mérouani, A., Lacroix, J., et al. (2007) Risk Factors of Acute Renal Failure in Critically Ill Children: A Prospective Descriptive Epidemiological Study. Pediatric Critical Care Medicine, 8, 29-35.  
https://doi.org/10.1097/01.pcc.0000256612.40265.67</mixed-citation></ref><ref id="scirp.95512-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Aloni, M.N., Nsibu, N.C., Meeko-Mimaniye, M., Ekulu, M.P. and Bodi, M.J. (2012) Acute Renal Failure in Congolese Children: A Tertiary Institution Experience. Acta Paediatrica, 101, 514-518. https://doi.org/10.1111/j.1651-2227.2012.02827.x</mixed-citation></ref><ref id="scirp.95512-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Keita, Y., Ka, E.F., Cissé, M.M., Sylla, A., Leye, M.M.M. and Lemrabott, A.T. (2015) L’insuffisance rénale aigue (IRA) chez l’enfant: Aspects diagnostiques, thé-rapeutiques, évolutifs et pronostiques à propos de 50 cas colligés dans un service de pédiatrie à Dakar. Revue Africaine et Malgache de RechercheScientifique/Sciences et Santé, 3, 55-60.</mixed-citation></ref><ref id="scirp.95512-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Ifeoma, C., Anochie, I.C. and Eke, F.U. (2005) Acute Renal Failure in Nigerian Children: Port Harcourt Experience. Pediatric Nephrology, 20, 1610-1614.  
https://doi.org/10.1007/s00467-005-1984-8</mixed-citation></ref><ref id="scirp.95512-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Coulibaly, G., Savadogo, H., Bakoné, B.E., Karambiri, A.R., Kouéta, F., Hien Kpienoba, M., et al. (2016) Epidemiology of Renal Failure in Children at the Pediatric University Hospital Charles De-Gaulle of Ouagadougou (Burkina Faso). Open Journal of Pediatrics, 6, 647-678. https://doi.org/10.4236/ojped.2016.61021</mixed-citation></ref><ref id="scirp.95512-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Assounga, A.G., Assambo-kieli, C., Mafoua, A., Moyen, G. and Nzingoula, S. (2000) Etiology and Outcome of Acute Renal Failure in Children in Congo-Brazzaville. Saudi Journal of Kidney Disease and Transplantation, 1, 40-43.</mixed-citation></ref><ref id="scirp.95512-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Perrouin-Verbe, M.A. and Phé, V. (2013) Insuffisance rénale aigue—Anurie. AFU. Item 343—UE 11.</mixed-citation></ref><ref id="scirp.95512-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Akcan-Arikan, A., Zappitelli, M., Loftis, L.L., Wasburn, K.K., Jefferson, L.S. and Goldstein, S.L. (2007) Modified Rifle Criteria in Critically Ill Children with Acute Kidney Injury. Kidney International, 71, 1028-1035.  
https://doi.org/10.1038/sj.ki.5002231</mixed-citation></ref><ref id="scirp.95512-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Schwartz, G.J., Haycock, G.B., Edelmann, C.M. and Spitzer, A. (1976) A Simple Estimate of Glomerular Filtration Rate in Children Derived from Body Length and Plasma Créatinine. Pediatrics, 58, 259-263.</mixed-citation></ref><ref id="scirp.95512-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Collège universitaire des enseignants de néphrologie (CUEN) (2010) Insuffisance rénale aigue. 22, 1-22.</mixed-citation></ref><ref id="scirp.95512-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Olowu, W.A., Adefehinti, O. and Bisiriyu, A.L. (2012) Hospital-Acquired Acute Kidney Injury in Critically Ill Children and Adolescents. Saudi Journal of Kidney Disease and Transplantation, 23, 68-77.</mixed-citation></ref><ref id="scirp.95512-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Batouche, D.D. and Kerboua, K. (2016) Prognosis of Acute Renal Failure in Children in Intensive Care Unit: A Pilot Study. Current Pediatric Research, 20, 193-198.</mixed-citation></ref><ref id="scirp.95512-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Bresolin, N., Silva, C., Halllal, A., Toporovski, J., Fernandes, V., Góes, J., et al. (2009) Prognosis for Children with Acute Kidney Injury in the Intensive Care Unit. Pediatric Nephrology, 24, 537-544. https://doi.org/10.1007/s00467-008-1054-0</mixed-citation></ref><ref id="scirp.95512-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Cao, Y., Yi, Z.W., Zhang, H., Dang, X.Q., Wu, X.C. and Huang, A.W. (2013) Etiology and Outcomes of Acute Kidney Injury in Chinese Children: A Prospective Multicentre Investigation. BMC Urology, 21, 41.  
https://doi.org/10.1186/1471-2490-13-41</mixed-citation></ref><ref id="scirp.95512-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Gheissari, A., Mehrasa, P., Merrikhi, A. and Madihi, Y. (2012) Acute Kidney Injury: A Pediatric Experience over 10 Years at a Tertiary Care Center. Journal of Nephropathology, 1, 101-108. https://doi.org/10.5812/nephropathol.7534</mixed-citation></ref><ref id="scirp.95512-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Bunchman, T.E., McBryde, K.D., Mottes, T.E., Gardner, J.J., Maxvold, N.J. and Brophy, P.D. (2001) Pediatric Acute Renal Failure: Outcome by Modality and Disease. Pediatric Nephrology, 16, 1067-1071. https://doi.org/10.1007/s004670100029</mixed-citation></ref><ref id="scirp.95512-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Tresa, V., Yaseen, A., Lanewala, A.A., Hashmi, S., Khatri, S., Ali, I., et al. (2017) Etiology, Clinical Profile and Short-Term Outcome of Acute Kidney Injury in Children at a Tertiary Care Pediatric Nephrology Center in Pakistan. Renal Failure, 39, 26-31. https://doi.org/10.1080/0886022X.2016.1244074</mixed-citation></ref><ref id="scirp.95512-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Riyuzo, M.C., Silveira, L.V., Macedo, C.S. and Fioretto, J.R. (2017) Predictive Factors of Mortality in Pediatric Patients with Acuterenal Injury Associated with Sepsis. Jornal de Pediatria, 93, 28-34. https://doi.org/10.1016/j.jped.2016.04.006</mixed-citation></ref><ref id="scirp.95512-ref25"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Abdullah</surname><given-names> S.Z. </given-names></name>,<etal>et al</etal>. (<year>2015</year>)<article-title>Peritoneal Dialysis in Children with Acute Renal Failure in Ibn Al-Balady Hospital</article-title><source> The Iraqi Postgraduate Medical Journal</source><volume> 14</volume>,<fpage> 1</fpage>-<lpage>6</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.95512-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Oubella, A., Ait Sab, I. and Sbihi, M. (2015) L’Insuffisance rénale aigue chez l’enfant au CHU de Mohamed VI à Marrakech. Thèse N X.</mixed-citation></ref><ref id="scirp.95512-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Moghtaderi, M., Yaghmaii, B. and Allahwerdi, B. (2014) Atteinte rénale aigue chez les enfants atteints de gastro-entérite aigue. Journal of Pediatric Nephrology, 2, 76-78.</mixed-citation></ref><ref id="scirp.95512-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Shalaby, M., Khathlan, N., Safder, O., Fadel, F., Farag, Y.M.K., Singh, A.K., et al. (2014) Outcome of Acute Kidney Injury in Pediatric Patients Admitted to the Intensive Care Unit. Clinical Nephrology, 82, 379-386.  
https://doi.org/10.5414/CN108348</mixed-citation></ref><ref id="scirp.95512-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Moussa Tondi, Z.M., Moussa Diongole, H., Abdou, I., Toure, E.M. and Aboubacar, I. (2015) Insuffisance rénale chez les enfants agés de 0 à 15 ans au Niger. Néphrologie &amp; Thérapeutique, 11, 435. https://doi.org/10.1016/j.nephro.2015.07.211</mixed-citation></ref><ref id="scirp.95512-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Shimelis, D., Abebe, B. and Deyessa, N. (2018) Incidence of Acute Kidney Injury and Determinant Factors in Children Admitted to a Tertiary Hospital. IOSR-JDMS, 17, 48-53.</mixed-citation></ref><ref id="scirp.95512-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Bhattacharya, M., Dhingra, D., Mantan, M., Upare, S. and Sethi, G.R. (2013) Acute Renal Failure in Children in a Tertiary Care Center. Saudi Journal of Kidney Disease and Transplantation, 24, 413-417. https://doi.org/10.4103/1319-2442.109620</mixed-citation></ref><ref id="scirp.95512-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Jenssen, G.R., Hovland, E., Bangstad, H.J., Nygard, K., Vold, L. and Bjerre, A. (2014) The Incidence and Aetiology of Acute Kidney Injury in Children in Norway between 1999 and 2008. Acta P&amp;aeligdiatrica, 103, 1192-1197.  
https://doi.org/10.1111/apa.12742</mixed-citation></ref><ref id="scirp.95512-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Vachvanichsanong, P., Dissaneewate, P., Lim, A. and McNeil, E. (2006) Childhood Acute Renal Failure: 22-Year Experience in a University Hospital in Southern Thailand. Pediatrics, 118, 786-791. https://doi.org/10.1542/peds.2006-0557</mixed-citation></ref><ref id="scirp.95512-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Duzova, A., Bakkaloglu, A., Kalyoncu, M., Poyrazoglu, H., Delibas, A., Ozkaya, O., et al. (2010) Etiology and Outcome of Acute Kidney Injury in Children. Pediatric Nephrology, 25, 1453-1461. https://doi.org/10.1007/s00467-010-1541-y</mixed-citation></ref><ref id="scirp.95512-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Jakanattane, V. and Mathivanan, M. (2017) Clinico-Etiological Profile of Acute Kidney Injury in Children Admitted to Paediatric Intensive Care Unit of a Tertiary Care Centre. International Journal of Research in Medical Sciences, 5, 4959-4964.  
https://doi.org/10.18203/2320-6012.ijrms20174952</mixed-citation></ref><ref id="scirp.95512-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Pundziene, B., Dobiliene, D. and Rudaitis, S. (2010) Acute Kidney Injury in Pediatric Patients: Experience of a Single Center during an 11-Year Period. Medicina (Kaunas), 46, 511-515. https://doi.org/10.3390/medicina46080073</mixed-citation></ref><ref id="scirp.95512-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Ismail, H.K., Hodan, M.J. and Li, C. (2017) A Retrospective Study of Acute Renal Failure in Children: Its Incidence, Etiology, Complications and Prognosis. Cureus, 9, e1274.</mixed-citation></ref><ref id="scirp.95512-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Halle, M.P., Tsou, L.C., Barla, E., Fouda, H., Djantio, H., Kaptue, M.B., et al. (2017) Epidemiology and Outcomes of Children with Renal Failure in the Pediatric Ward of a Tertiary Hospital in Cameroon. BMC Pediatrics, 17, 202.  
https://doi.org/10.1186/s12887-017-0955-0</mixed-citation></ref><ref id="scirp.95512-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Afroz, S., Simi, M.A., Sharmim, S., Khanum, R., Yeasmin, L., Kundo, L.C., et al. (2015) A Etiology and Outcome of Acute Kidney Failure in Bangladesh Children—Dhaka Medical College Hospital Experience. Journal of Dhaka Medical College, 24, 86-91. https://doi.org/10.3329/jdmc.v24i2.29615</mixed-citation></ref><ref id="scirp.95512-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Ghani, A.A., Helal, B.A. and Hussain, N. (2009) Acute Renal Failure in Pediatric Patients: Etiology and Predictors of Outcome. Saudi Journal of Kidney Disease and Transplantation, 20, 69-76.</mixed-citation></ref><ref id="scirp.95512-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Diarrassouba, G., Adonis-Koffy, L., Niamien, E., Yaokreh, J.B. and Coulibaly, P.A. (2015) Acute Peritoneal Dialysis in African Pediatric Area Experience of Pediatric Nephrology Unit of Yopougon University Hospital (Abidjan, Cote d’Ivoire). Blood Purification, 39, 141-144. https://doi.org/10.1159/000368938</mixed-citation></ref><ref id="scirp.95512-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Hui, W.F., Chan, W.K. and Miu, T.Y. (2013) Acute Kidney Injury in the Paediatric Intensive Care Unit: Identification by Modified Rifle Criteria. Hong Kong Medical Journal, 19, 13-19.</mixed-citation></ref><ref id="scirp.95512-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">Balaka, B., Douti, K., Gnazingbe, E., Bakonde, B., Agbere, A.D. and Kessie, K. (2012) Etiologies et pronostic de l’insuffisance rénale de l’enfant à l’hopital universitaire de Lomé. Journal de la Recherche Scientifique de l'Université de Lomé (Togo), 14, 11-18.</mixed-citation></ref><ref id="scirp.95512-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">Kaddourah, A., Basu, R.K., Bagshaw, S.M. and Goldstein, S.L. (2017) Epidemiology of Acute Kidney Injury in Critically Ill Children and Young Adults. The New England Journal of Medicine, 376, 11-20. https://doi.org/10.1056/NEJMoa1611391</mixed-citation></ref><ref id="scirp.95512-ref45"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hooman</surname><given-names> N. </given-names></name>,<etal>et al</etal>. (<year>2014</year>)<article-title>Acute Kidney Injury in Iranian Children—What Do We Know About It?—Part 2</article-title><source> Journal of Pediatric Nephrology</source><volume> 2</volume>,<fpage> 98</fpage>-<lpage>103</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.95512-ref46"><label>46</label><mixed-citation publication-type="other" xlink:type="simple">Otukesh, H., Hoseini, R., Hooman, N., Chalian, M., Chalian, H. and Tabarroki, A. (2006) Prognosis of Acute Renal Failure in Children. Pediatric Nephrology, 21, 1873-1878. https://doi.org/10.1007/s00467-006-0240-1</mixed-citation></ref></ref-list></back></article>